57
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Overexpression of c-kit(CD117), relevant with microvessel density, is an independent survival prognostic factor for patients with HBV-related hepatocellular carcinoma

, , , &
Pages 1285-1292 | Published online: 07 Mar 2018

References

  • TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
  • Tung-Ping PoonRFanSTWongJRisk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinomaAnn Surg20002321102410862190
  • BeckerGSchmitt-GraeffAErteltVBlumHEAllgaierHPCD117 (c-kit) expression in human hepatocellular carcinomaClin Oncol (R Coll Radiol)200719320420817359908
  • KimJHSohnBHLeeHSGenomic predictors for recurrence patterns of hepatocellular carcinoma: model derivation and validationPLoS medicine20141112e100177025536056
  • YamamotoTUenishiTOgawaMImmunohistologic attempt to find carcinogenesis from hepatic progenitor cell in hepatocellular carcinomaDig Surg200522536437016374007
  • WangFSFanJGZhangZGaoBWangHYThe global burden of liver disease: the major impact of ChinaHepatology20146062099210825164003
  • MutoJShirabeKSugimachiKMaeharaYReview of angiogenesis in hepatocellular carcinomaHepatol Res20154511924533487
  • CarmelietPJainRKMolecular mechanisms and clinical applications of angiogenesisNature2011473734729830721593862
  • Di CarloIFraggettaFLombardoRAzzarelloGVasquezEPuleoSCD 34 expression in chronic and neoplastic liver diseasesPanminerva Med200244436536712434120
  • PoonRTNgIOLauCTumor microvessel density as a predictor of recurrence after resection of hepatocellular carcinoma: a prospective studyJ Clin Oncol20022071775178511919234
  • UzzanBNicolasPCucheratMPerretGYMicrovessel density as a prognostic factor in women with breast cancer: a systematic review of the literature and meta-analysisCancer Res20046492941295515126324
  • WiedmannMWCacaKMolecularly targeted therapy for gastrointestinal cancerCurr Cancer Drug Targets20055317119315892618
  • CohenMHJohnsonJRJusticeRPazdurRApproval summary: imatinib mesylate for one or three years in the adjuvant treatment of gastrointestinal stromal tumorsThe oncologist201217799299722643537
  • KaraBDoranFKaraIOAkkizHSandikciMExpression of c-kit protooncogen in hepatitis B virus-induced chronic hepatitis, cirrhosis and hepatocellular carcinoma: has it a diagnostic role?Int J Clin Pract20086281206121118284441
  • LeeESHanEMKimYSOccurrence of c-kit+ tumor cells in hepatitis B virus-associated hepatocellular carcinomaAm J Clin Pathol20051241313615923163
  • van der ZeeJAvan EijckCHHopWCAngiogenesis: a prognostic determinant in pancreatic cancer?Eur J Cancer201147172576258421958461
  • WuLQLuYLuHJLvZHCan E-cadherin and CD34 be used as indicators of prognosis for hepatocellular carcinoma patients?Clin Chem Lab Med20084681122112618724809
  • MurakamiKKasajimaAKawagishiNOhuchiNSasanoHMicrovessel density in hepatocellular carcinoma: prognostic significance and review of the previous published workHepatol Res201545121185119425594920
  • BruixJShermanMAmerican Association for the Study of Liver DManagement of hepatocellular carcinoma: an updateHepatology20115331020102221374666
  • European Association for the Study of the Liver, European Organisation for Research and Treatment of CancerEASL-EORTC clinical practice guidelines: management of hepatocellular carcinomaJ Hepatol201256490894322424438
  • ChenLShiYJiangCYCoexpression of PDGFR-alpha, PDGFR-beta and VEGF as a prognostic factor in patients with hepatocellular carcinomaInt J Biol Markers201126210811621574155
  • NguyenVTLawMGDoreGJHepatitis B-related hepatocellular carcinoma: epidemiological characteristics and disease burdenJ Viral Hepat200916745346319302335
  • SasakiYYamadaTTanakaHRisk of recurrence in a long-term follow-up after surgery in 417 patients with hepatitis B- or hepatitis C-related hepatocellular carcinomaAnn Surg2006244577178017060771
  • SalizzoniMRomagnoliRLupoFMicroscopic vascular invasion detected by anti-CD34 immunohistochemistry as a predictor of recurrence of hepatocellular carcinoma after liver transplantationTransplantation200376584484814501865
  • WangW-QLiuLXuH-XIntratumoral alpha-SMA enhances the prognostic potency of CD34 associated with maintenance of microvessel integrity in hepatocellular carcinoma and pancreatic cancerPLoS One201388e7118923940715
  • WentPTDirnhoferSBundiMPrevalence of KIT expression in human tumorsJ Clin Oncol200422224514452215542802
  • MoriniMBettiniGPreziosiRMandrioliLC-kit gene product (CD117) immunoreactivity in canine and feline paraffin sectionsJ Histochem Cytochem200452570570815100248
  • KnightBTirnitz-ParkerJEOlynykJKC-kit inhibition by imatinib mesylate attenuates progenitor cell expansion and inhibits liver tumor formation in miceGastroenterology20081353969979979 e96118602920